← Evidence map

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Triple-Negative Receptor Conversion at Metastatic Sites Might Show Better Efficacy in Patients Who Received Sacituzumab Govitecan.

Kadri AltundagPubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 36608300